Cenduit LLC Chief Operating Officer Jennifer Aquino Named One of the 2018 PharmaVOICE 100 Most Influential Professionals in Life Sciences


Durham, NC – Aug. 1, 2018  – Cenduit LLC announced Chief Operating Officer Jennifer Aquino has been named to the prestigious PharmaVOICE 100 list of the most influential and inspiring professionals in the life sciences industry. Aquino was chosen for this year’s list for her accomplishments and commitment to helping biopharma organizations build quality clinical trial drug programs that accelerate the delivery of new medicines while putting patients first. You can read her full profile here/LINK.

Cenduit CEO Sam Osman commented, “At Cenduit, we believe that the patient comes first. Quality matters in an industry ripe with risk. Jennifer’s ‘quality first’ philosophy has been a welcome addition, seamlessly connecting the company’s innovation and expertise. As we continue to set the bar higher, I am proud to see this mindset embodied through both Jennifer and our entire global team. I join everyone at Cenduit in congratulating Jennifer on this much-deserved recognition.”

PharmaVOICE Co-Founder and Editor-in-Chief Taren Grom explained, “Jennifer Aquino’s achievements and vision to improve the safety, speed, and integrity of drug programs personifies the best in our industry as we all work together to improve clinical research. Additionally, Jennifer is fostering a globally inclusive, collaborative, and innovative environment that helps her teams achieve their professional goals and become leaders who also make a difference.”

Jennifer Aquino has 25 years of extensive experience in biopharma operational leadership, clinical technology, and regulatory and compliance. She has developed systems and operational teams that support digital health solutions including ePRO/eCOA, EDC, CTMS, and regulatory submissions at sponsor and CRO organizations. In addition to overseeing Cenduit’s global expansion, Aquino continually innovates Cenduit’s service delivery to help clients navigate clinical programs more simply. Her experience also includes serving as a compliance lead at Shire, supporting their R&D group. Aquino also held senior leadership roles at PAREXEL in the U.S. and Europe, where she had general manager responsibility for their largest IRT delivery center.

Jennifer Aquino said, “It’s a tremendous honor to join the extraordinary members of the PharmaVOICE 100, who’ve devoted their careers to improving outcomes and healthcare. I share this acknowledgement with our clients and especially my colleagues at Cenduit who are dedicated to delighting our clients every day while always remembering that ultimately we’re serving the patients participating in the trials we support.”

Aquino’s honors also include being chosen as an Executive Representative to a Leadership and Diversity program in the EU. She is a member of the Healthcare Businesswomen’s Association (HBA) and is involved in the Women in Leadership group of the Linkage Institute.

She concluded, “Clinical trials are changing quickly. As sponsors are able to make decisions faster than ever technology solutions providers need to be much more flexible and nimble in a complex, adaptive trial landscape. We all have a responsibility to improve patient outcomes, and a broader responsibility to help improve healthcare in the world. We’re lucky to live in a time where so many people have access to incredibly good healthcare. I’m honored to join with my fellow members of this year’s PharmaVOICE 100 to do all I can to help make sure every patient, everywhere, has that same access in the future.”

About Cenduit LLC

Cenduit enables clinical study sponsors and CROs to safely, quickly and economically deliver new drugs and therapies that improve and save lives. As the world leader in quality IRT systems, Cenduit accelerates study startup, with clinical supply chain intelligence, deep clinical operations expertise and client-centric CORE teams. With 500+ experts throughout the US, Europe and Asia, Cenduit helps customers manage clinical studies in over 100 countries, interacting with nearly 1,000,000 patients at over 32,000 sites. Visit www.cenduit.com for more information.


Shannon L. Davies, Shannon.lappindavies@cenduit.com, +1 919-998-3393

Brenda Nashawaty, brenda@nashawaty.com, +1 617-688-3253